Navigation Links
Landauer Elects Board Member Michael T. Leatherman as Interim Chief Financial Officer

GLENWOOD, Ill., Aug. 25, 2011 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR) today announced that its Board of Directors has appointed, Michael T. Leatherman, as the Company's Interim Chief Financial Officer, as well as its acting principal financial officer and principal accounting officer, effective September 9, 2011. Leatherman succeeds Jonathon Singer, who had served as CFO since October 2006 and has left the Company in order to accept the chief financial officer position with Sagent Pharmaceuticals, Inc.

"Mike has worked with Landauer since 2003, and he has been a Board member for the last three years. He has deep knowledge and history with the Company, understands our core radiation monitoring business and has been instrumental in shaping our growth strategy initiatives. The Board and I are confident that Mike will provide strong continuity as CFO and Treasurer as we search for a permanent Chief Financial Officer," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.

Mr. Leatherman, age 58, has been a Director of the Company since 2008.  Since 2000, Mr. Leatherman has served as an Independent Consultant, primarily to the information technology industry.  Mr. Leatherman is a Certified Public Accountant and previously served as the Chief Financial Officer of Wallace Computer Services, Inc., which prior to its acquisition by Moore Corporation was a NYSE-listed company.

During his term as Interim Chief Financial Officer, Mr. Leatherman will continue to serve as a director of the Company, but will cease his service as a member of the Audit Committee and Compensation Committee of the Company's Board of Directors.  The Company intends to conduct an executive search for a permanent Chief Financial Officer to replace Mr. Singer.

"The Board of Directors thanks Jon for his contributions to the Company.  He played an important role with Landauer during his time with the Company.  We wish him well in his new endeavor," noted Robert Cronin, Chairman of the Board of Directors.

About Landauer, Inc.

Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.6 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community.

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Reports Fiscal 2011 Third Quarter Results
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2011 Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2011 Results
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
7. Landauer, Inc. Declares Regular Cash Dividend
8. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
9. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
10. Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market
11. InspireMD Elects Two New Board Members
Post Your Comments:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: ) , ... , TwinLink™ - the first dual communication ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 27, 2016 , ... Quality metrics are ... in many ways they remain in the eye of the beholder, according to experts ... publication of The American Journal of Managed Care. For the full issue, click ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
Breaking Medicine News(10 mins):